Vaxart, Inc. Gains 33.33%

Tue 21 Apr 20 at 05:30 PM
Vaxart, Inc. Gains 33.33%

Vaxart, Inc. (VXRT:NASDAQ) rocketted at $3.16, representing a gain of 33.3%. On Mon 20 Apr 20, VXRT:NASDAQ touched a New 2-Week High of $2.37. The stock got featured on our News Catalysts scanner on Tue 21 Apr 20 at 11:57 AM in the 'BIOTECH' category. From Mon 06 Apr 20, the stock recorded 55.56% Up Days and 80.00% Green Days

The stock spiked on Fri 28 Feb 20 at $3.5 with a volume of 29M+.

About Vaxart, Inc. (VXRT:NASDAQ)

Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.